10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
Merus N.v. (MRUS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 189,098 | $7,959,135 | 2.23% | |
| 2. | Impax Asset Management Ian Simm | 180,000 | $7,576,200 | 0.05% | |
| 3. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 35,292 | $1,485,440 | -44% | 0.66% |
| 4. | BIT Capital GmbH Jan Beckers | 29,612 | $1,246,369 | +39% | 0.11% |
| 5. | Hurley Capital Charles Goldblum | 305 | $12,837 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.38 | 14,706 | Officer, Director | 40,576 | 2022-11-03 | Filing | |
| $22.92 | 5,826 | Officer, Director | 25,870 | 2022-08-22 | Filing | |
| $22.99 | 704 | Officer, Director | 20,044 | 2022-08-19 | Filing | |
| $22.97 | 4,340 | Officer, Director | 19,340 | 2022-07-12 | Filing | |
| $19.75 | 26,894 | Large Shareholder | 462,015 | 2021-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $48.55 | 1,000 | 11,002 | 2025-03-21 | Filing | ||
| $48.48 | 3,000 | 12,002 | 2025-03-21 | Filing | ||
| $54.00 | 2,500 | 7,002 | 2024-08-21 | Filing | ||
| $54.00 | 2,500 | 7,002 | 2024-08-20 | Filing | ||
| $60.00 | 10,000 | 0 | 2024-06-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,691,869 | $71,210,764 | 0% | |
| 2. | 1,501,220 | $63,186,350 | 0.31% | |
| 3. | 1,044,625 | $43,968,266 | 0.09% | |
| 4. | 1,032,101 | $43,441,131 | 0.05% | |
| 5. | 343,705 | $14,466,543 | 0.23% |
News See All
10 Best High Short Interest Stocks to Buy Now
Aditya Bhave, BofA Securities head of US Economics, joined 'Power Lunch' on CNBC on April 17 to talk about whether tariffs are ultimately inflationary, disinflationary, or deflationary.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Jim Cramer Stocks to Watch in 2025
Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” because when the stocks rise no one would remember your outlook but if they...
Jim Cramer's Lightning Rounds: 12 Stocks Under the Spotlight
Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations for Federal Reserve rate...
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.
10 Top Performing European Stocks Heading into 2025
As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low. The consumer price index increased 2% in October as compared to the year earlier.
TimesSquare Capital Management U.S. Small Cap Growth Strategy Established a Position in Merus N.V. (MRUS)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter.
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
Top 10 ADR Stocks To Buy According to Hedge Funds
Diversifying an investment portfolio is one of the best ways of spreading risk and minimizing the impact of heightened volatility.